High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone. (Q46025960)
Jump to navigation
Jump to search
scientific article published on 9 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone. |
scientific article published on 9 April 2013 |
Statements
1 reference
High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone. (English)
1 reference
Antonio Palumbo
1 reference
Heinz Ludwig
1 reference
Daniel Heintel
1 reference
Alberto Rocci
1 reference
Arnold Bolomsky
1 reference
Simona Caltagirone
1 reference
Martin Schreder
1 reference
Sabine Pfeifer
1 reference
Heinz Gisslinger
1 reference
Niklas Zojer
1 reference
Ulrich Jäger
1 reference
9 April 2013
1 reference
161
1 reference
5
1 reference
695-700
1 reference
Identifiers
1 reference